Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis

- Baker, Jonathan R., Mahdi, Mahdi, Nicolau, Dan V., Ramakrishnan, Sanjay, Barnes, Peter J., Simpson, Jodie L., Cass, Steven P., Russell, Richard E. K., Donnelly, Louise E., Bafadhel, Mona

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

- Ramakrishnan, Sanjay, Nicolau, Dan V., Bright, Stephen, Butler, Christopher, Cane, Jennifer L., Halner, Andreas, Matthews, Philippa C., Donnelly, Louise E., Simpson, Jodie L., Baker, Jonathan R., Fadai, Nabil T., Peterson, Stefan, Langford, Beverly, Bengtsson, Thomas, Barnes, PJ, Russell, REK, Bafadhel, M, Mahdi, Mahdi, Jeffers, Helen, Mwasuku, Christine, Krassowska, Karolina, Fox, Robin, Binnian, Ian, Glover, Victoria